Angiographic monitoring of reperfusion therapy for acute myocardial infarction. TIMI grade 3 perfusion is the goal.

This publication has 20 references indexed in Scilit:

• Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study
  Journal of the American College of Cardiology, 1992
• Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction
  The American Journal of Cardiology, 1989
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1989
• Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Controlled comparison with intracoronary streptokinase
  Journal of the American College of Cardiology, 1988
• Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction
  The American Journal of Cardiology, 1988
• A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
  New England Journal of Medicine, 1987
• The Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
  New England Journal of Medicine, 1985
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985
• Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
  Circulation, 1984